BCS

Biosimilars & Switches · Manchester

Biosimilars & Switches in Manchester.

Pharmacist-led biosimilar and formulary switches — ICB-priority molecules switched, patients counselled, evidence captured. Delivered to Manchester PCNs and GP practices from the BCS Halifax (West Yorkshire) hub — with paired cover from our Chiswick (West London) hub. BCS is the only UK provider operating this dual-hub clinical pharmacy model.
Talk to us about Manchester Medicines Optimisation

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every biosimilar and formulary switches placement in Manchester is mobilised from one of our two clinical hubs — Halifax (West Yorkshire) as the lead and Chiswick (West London) as paired cover. The dual-hub model is unique to BCS: no other clinical pharmacy provider in the UK runs Northern and Southern hubs with shared SOPs, shared supervision and same-week cross-cover. That is what guarantees continuity of biosimilar and formulary switches for a Manchester PCN through sickness, leave and turnover.

  • Lead delivery from the BCS Halifax (West Yorkshire) hub
  • Paired cover from BCS Chiswick (West London) — same SOPs, same supervision
  • Same-week sickness, leave and maternity cover guaranteed
  • ARRS-compliant, GPhC-registered, IP-qualified workforce
  • One SLA, one report, one escalation point

Manchester · local context

Manchester PCNs sit within NHS Greater Manchester ICB (Manchester place).

Manchester PCNs work with MFT — England's largest acute trust — so discharge medicines reconciliation throughput is the single biggest BCS technician workstream.

For biosimilar and formulary switches specifically, the Manchester pathway often integrates with Manchester University NHS Foundation Trust (MFT). BCS standardises the cross-organisation workflow into a single hub-supervised process so a Manchester Clinical Director never has to chase two systems for one outcome.

What you get

What biosimilars & switches in Manchester actually looks like.

  • ICB-priority biosimilar switches
  • Formulary alignment audits
  • Patient counselling and consent
  • Switch evidence pack for ICB
  • Monthly switch volumes reported

Manchester · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Manchester
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Manchester PCNs choose BCS for biosimilar and formulary switches.

Solo recruitment for biosimilar and formulary switches in Manchester leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Halifax (West Yorkshire)/Chiswick (West London) dual-hub.

Whether you are a single Manchester PCN starting your first biosimilar and formulary switches programme, or a federation coordinating biosimilar and formulary switches across multiple North West networks, the BCS managed model scales without changing your contract.

Frequently asked questions — Biosimilars & Switches in Manchester.

Do you run the patient consent process?+

Yes — every switch includes pharmacist-led counselling and consent capture.

Does BCS already deliver biosimilar and formulary switches in Manchester?+

BCS supports PCNs and GP practices across North West from our Halifax (West Yorkshire) hub with paired cover from Chiswick (West London), and is actively delivering or available to mobilise biosimilar and formulary switches in Manchester. Get in touch and we'll confirm current capacity.

What makes the dual-hub model different?+

BCS is the only UK clinical pharmacy provider running both a Northern (Halifax) and Southern (Chiswick) hub. That means same-week cross-cover, one SOP set across the country, and no service gap when staff are off — something single-hub or single-region providers cannot match.

How quickly can BCS mobilise biosimilar and formulary switches in Manchester?+

In most cases BCS mobilises biosimilar and formulary switches for a Manchester PCN within 4 to 6 weeks of contract sign-off, with remote prescribing back-up available from the hub sooner if needed.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call

Related medicines optimisation topics in Manchester

More medicines optimisation pages for Manchester.

Nearby PCN areas

Biosimilars & Switches elsewhere in Greater Manchester.

Medicines Optimisation pillar →All BCS in Manchester →About our two hubs →